Cetera Investment Advisers’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-800
Closed -$728 4169
2025
Q1
$728 Hold
800
﹤0.01% 3971
2024
Q4
$4.24K Hold
800
﹤0.01% 3744
2024
Q3
$2.57K Buy
800
+100
+14% +$8.41K ﹤0.01% 3695
2024
Q2
$3.36K Sell
700
-100
-13% -$8.2K ﹤0.01% 3690
2024
Q1
$2.07K Buy
800
+400
+100% +$34.1K ﹤0.01% 3672
2023
Q4
$960 Hold
400
﹤0.01% 2223
2023
Q3
$2.74K Hold
400
﹤0.01% 2183
2023
Q2
$944 Sell
400
-100
-20% -$8.61K ﹤0.01% 2179
2023
Q1
$800 Sell
500
-100
-17% -$8.15K ﹤0.01% 2151
2022
Q4
$4.26K Buy
+600
New +$48.6K ﹤0.01% 2091

Other funds holding MDT

Cetera Investment Advisers's MDT Position: Q1 2026 in Review

Cetera Investment Advisers increased its Medtronic (MDT) stake by 7.4% in Q1 2026, buying an estimated $4.57M and bringing the position to 696,767 shares worth $60.4M. The position accounts for 0.06% of the portfolio, ranked #302.

Cetera Investment Advisers first reported a position in MDT in Q3 2017 and has held it in 35 quarters since. The position peaked at $62.3M in Q4 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Cetera Investment Advisers held 696,767 shares of Medtronic worth $60.4M as of Q1 2026.
  • Cetera Investment Advisers bought 47,721 Medtronic shares in Q1 2026, an estimated $4.57M.
  • Medtronic made up 0.06% of Cetera Investment Advisers's portfolio in Q1 2026, its #302 holding.
  • Cetera Investment Advisers first reported a position in Medtronic in Q3 2017 and has held it in 35 quarters since.
  • Cetera Investment Advisers's Medtronic position peaked at $62.3M in Q4 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.